Meiji Yasuda Life Insurance’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Sell
14,621
-96
-0.7% -$8.56K 0.04% 124
2025
Q4
$1.16M Sell
14,717
-6,440
-30% -$505K 0.03% 122
2025
Q3
$1.69M Buy
21,157
+3,975
+23% +$339K 0.05% 102
2025
Q2
$1.56M Buy
17,182
+4,371
+34% +$399K 0.05% 106
2025
Q1
$1.2M Sell
12,811
-5,721
-31% -$512K 0.02% 137
2024
Q4
$1.68M Buy
18,532
+6,200
+50% +$592K 0.03% 112
2024
Q3
$1.28M Buy
12,332
+10,072
+446% +$1.03M 0.02% 130
2024
Q2
$219K Sell
2,260
-140
-6% -$12.9K ﹤0.01% 236
2024
Q1
$216K Sell
2,400
-3,507
-59% -$297K ﹤0.01% 256
2023
Q4
$471K Buy
5,907
+1,978
+50% +$149K 0.01% 224
2023
Q3
$279K Buy
+3,929
New +$294K 0.01% 246
2023
Q2
Sell
-8,793
Closed -$661K 265
2023
Q1
$661K Sell
8,793
-1,041
-11% -$77.4K 0.01% 202
2022
Q4
$775K Buy
9,834
+2,010
+26% +$151K 0.02% 179
2022
Q3
$550K Buy
7,824
+3,837
+96% +$301K 0.01% 201
2022
Q2
$320K Buy
+3,987
New +$312K 0.01% 240
2022
Q1
Sell
-4,133
Closed -$353K 299
2021
Q4
$353K Sell
4,133
-8,700
-68% -$679K 0.01% 262
2021
Q3
$970K Sell
12,833
-2,700
-17% -$214K 0.02% 156
2021
Q2
$1.26M Buy
15,533
+2,522
+19% +$206K 0.02% 137
2021
Q1
$1.03M Buy
13,011
+200
+2% +$15.7K 0.02% 147
2020
Q4
$1.09M Sell
12,811
-4,642
-27% -$384K 0.02% 140
2020
Q3
$1.35M Buy
17,453
+1,922
+12% +$147K 0.03% 126
2020
Q2
$1.14M Buy
15,531
+568
+4% +$40.3K 0.04% 132
2020
Q1
$993K Sell
14,963
-597
-4% -$42.1K 0.2% 123
2019
Q4
$1.07M Sell
15,560
-854
-5% -$58.2K 0.15% 153
2019
Q3
$1.21M Sell
16,414
-560
-3% -$40.6K 0.17% 142
2019
Q2
$1.22M Sell
16,974
-1,908
-10% -$135K 0.18% 136
2019
Q1
$1.29M Sell
18,882
-3,026
-14% -$195K 0.2% 129
2018
Q4
$1.3M Sell
21,908
-2,646
-11% -$166K 0.2% 126
2018
Q3
$1.64M Sell
24,554
-800
-3% -$53.3K 0.21% 130
2018
Q2
$1.64M Hold
25,354
0.23% 117
2018
Q1
$1.82M Sell
25,354
-1,080
-4% -$77.7K 0.28% 95
2017
Q4
$1.99M Buy
26,434
+8,540
+48% +$624K 0.27% 93
2017
Q3
$1.3M Sell
17,894
-3,700
-17% -$267K 0.19% 138
2017
Q2
$1.6M Buy
21,594
+4,200
+24% +$312K 0.25% 106
2017
Q1
$1.27M Sell
17,394
-2,700
-13% -$189K 0.2% 133
2016
Q4
$1.31M Buy
20,094
+2,810
+16% +$193K 0.22% 115
2016
Q3
$1.28M Sell
17,284
-3,400
-16% -$251K 0.17% 165
2016
Q2
$1.51M Sell
20,684
-5,680
-22% -$404K 0.24% 119
2016
Q1
$1.86M Buy
26,364
+1,850
+8% +$123K 0.29% 98
2015
Q4
$1.63M Hold
24,514
0.26% 112
2015
Q3
$1.56M Buy
24,514
+300
+1% +$19.6K 0.26% 108
2015
Q2
$1.58M Sell
24,214
-300
-1% -$20.4K 0.25% 117
2015
Q1
$1.7M Buy
24,514
+662
+3% +$45.8K 0.26% 111
2014
Q4
$1.65M Buy
23,852
+2,000
+9% +$135K 0.24% 99
2014
Q3
$1.43M Buy
21,852
+125
+0.6% +$8.24K 0.22% 112
2014
Q2
$1.48M Buy
21,727
+700
+3% +$46.9K 0.23% 102
2014
Q1
$1.36M Sell
21,027
-630
-3% -$39.7K 0.24% 104
2013
Q4
$1.41M Sell
21,657
-3,030
-12% -$194K 0.24% 100
2013
Q3
$1.46M Sell
24,687
-3,848
-13% -$228K 0.27% 93
2013
Q2
$1.64M Buy
+28,535
New +$1.69M 0.3% 75

Other funds holding CL

Meiji Yasuda Life Insurance's CL Position: Q1 2026 in Review

Meiji Yasuda Life Insurance reduced its Colgate-Palmolive (CL) stake by 0.65% in Q1 2026, selling an estimated $8.56K and leaving 14,621 shares worth $1.25M. The position accounts for 0.04% of the portfolio, ranked #124.

Meiji Yasuda Life Insurance first reported a position in CL in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.99M in Q4 2017. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Meiji Yasuda Life Insurance held 14,621 shares of Colgate-Palmolive worth $1.25M as of Q1 2026.
  • Meiji Yasuda Life Insurance sold 96 Colgate-Palmolive shares in Q1 2026, an estimated $8.56K.
  • Colgate-Palmolive made up 0.04% of Meiji Yasuda Life Insurance's portfolio in Q1 2026, its #124 holding.
  • Meiji Yasuda Life Insurance first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 50 quarters since.
  • Meiji Yasuda Life Insurance's Colgate-Palmolive position peaked at $1.99M in Q4 2017.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Meiji Yasuda Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.